{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:46:23Z","timestamp":1775277983086,"version":"3.50.1"},"reference-count":18,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,3,31]]},"DOI":"10.1536\/ihj.25-683","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:10:49Z","timestamp":1774908649000},"page":"150-155","source":"Crossref","is-referenced-by-count":0,"title":["Utility of Acute Vasodilator Challenge with Inhaled Nitric Oxide to Predict Pulmonary Hemodynamic Reversibility in Patients with Pulmonary Hypertension due to Left Heart Disease Referred for Heart Transplantation"],"prefix":"10.1536","volume":"67","author":[{"given":"Kei","family":"Morishita","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"},{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"},{"name":"Department of Advanced Medical Center for Heart Failure, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Minatsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isotani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Bujo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsura","family":"Soma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Abramson SV, Burke JF, Kelly JJ, <i>et al<\/i>. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992; 116: 888-95.","DOI":"10.7326\/0003-4819-116-11-888"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ghio S, Gavazzi A, Campana C, <i>et al<\/i>. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37: 183-8.","DOI":"10.1016\/S0735-1097(00)01102-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kjaergaard J, Akkan D, Iversen KK, <i>et al<\/i>. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 2007; 99: 1146-50.","DOI":"10.1016\/j.amjcard.2006.11.052"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vakil K, Kazmirczak F, Kittleson M, <i>et al<\/i>. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis. Int J Cardiol 2014; 176: 595-9.","DOI":"10.1016\/j.ijcard.2014.08.072"},{"key":"5","unstructured":"5. Peled Y, Ducharme A, Kittleson M, <i>et al<\/i>. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant 2024; 43: 1529-628.e54."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morales-Blanhir J, Santos S, de Jover L, <i>et al<\/i>. Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension. Respir Med 2004; 98: 225-34.","DOI":"10.1016\/j.rmed.2003.09.019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Humbert M, Kovacs G, Hoeper MM, <i>et al<\/i>. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension [published correction appears in Eur Heart J 2023; 44: 1312]. Eur Heart J 2022; 43: 3618-31.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Satoh T, Yaoita N, Nochioka K, <i>et al<\/i>. Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases. ESC Heart Fail 2023; 10: 3592-603.","DOI":"10.1002\/ehf2.14515"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Strong C, Raposo L, Castro M, <i>et al<\/i>. Haemodynamic effects and potential clinical implications of inhaled nitric oxide during right heart catheterization in heart transplant candidates. ESC Heart Fail 2020; 7: 673-81.","DOI":"10.1002\/ehf2.12639"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Grupper A, Mazin I, Faierstein K, <i>et al<\/i>. Hemodynamic changes after left ventricular assist device implantation among heart failure patients with and without elevated pulmonary vascular resistance. Front Cardiovasc Med 2022; 9: 875204.","DOI":"10.3389\/fcvm.2022.875204"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Selim AM, Wadhwani L, Burdorf A, <i>et al<\/i>. Left ventricular assist devices in pulmonary hypertension group 2 with significantly elevated pulmonary vascular resistance: a bridge to cure. Heart Lung Circ 2019; 28: 946-52.","DOI":"10.1016\/j.hlc.2018.04.299"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kutty RS, Parameshwar J, Lewis C, <i>et al<\/i>. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac Surg 2013; 43: 1237-42.","DOI":"10.1093\/ejcts\/ezs678"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shaw SM, Venkateswaran R, Hogg R, <i>et al<\/i>. Durable left ventricular assist device support as a bridge to heart transplant candidacy. Interact Cardiovasc Thorac Surg 2019; 28: 594-601.","DOI":"10.1093\/icvts\/ivy288"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zimpfer D, Zrunek P, Roethy W, <i>et al<\/i>. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007; 133: 689-95.","DOI":"10.1016\/j.jtcvs.2006.08.104"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kakuda N, Amiya E, Hatano M, <i>et al<\/i>. Residual pulmonary vascular resistance increase under left ventricular assist device support predicts long-term cardiac function after heart transplantation. Front Cardiovasc Med 2022; 9: 904350.","DOI":"10.3389\/fcvm.2022.904350"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chang PP, Longenecker JC, Wang NY, <i>et al<\/i>. Mild vs severe pulmonary hypertension before heart transplantation: different effects on post transplantation pulmonary hypertension and mortality. J Heart Lung Transplant 2005; 24: 998-1007.","DOI":"10.1016\/j.healun.2004.07.013"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen JM, Levin HR, Michler RE, <i>et al<\/i>. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 1997; 114: 627-34.","DOI":"10.1016\/S0022-5223(97)70053-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Crawford TC, Leary PJ, Fraser CD 3rd, <i>et al<\/i>. Impact of the new pulmonary hypertension definition on heart transplant outcomes: expanding the hemodynamic risk profile. Chest 2020; 157: 151-61.","DOI":"10.1016\/j.chest.2019.07.028"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/2\/67_25-683\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:49:13Z","timestamp":1775274553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/2\/67_25-683\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-683","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"25-683"}}